Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine

Clinical Infectious Diseases

Volumn 21, Issue 4, 1995, Pages 973-976

  Olano, Juan P ^a   Borucki, Michael J ^a   Wen, Julie W ^a   Haque, Abida K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FLUCONAZOLE; ISONIAZID; PYRIDOXINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; ECHOGRAPHY; ESOPHAGITIS; FATTY LIVER; FEMALE; HEPATITIS B; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LACTIC ACIDOSIS; LIVER FAILURE; LYMPHOCYTE COUNT; MEDICAL RECORD; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; THRUSH; TUBERCULIN TEST;

ACIDOSIS, LACTIC; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ALANINE TRANSAMINASE; BILIRUBIN; CASE REPORT; FAT NECROSIS; FATAL OUTCOME; FEMALE; HUMAN; LACTATE DEHYDROGENASE; LIVER DISEASES; ZIDOVUDINE;

EID: 0028805297     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/21.4.973     Document Type: Article

References (19)

1. Glasgow BJ, Anders K, Layfield LJ, Steinsapir KD, Gitnick GL, Lewin KJ. Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS). Am J Clin Pathol 1985;83:582-8.
2. Nakanuma Y, Liew CT, Peters RL, Govindarajan S. Pathologic features of the liver in acquired immune deficiency syndrome (AIDS). Liver 1986;6:158-66.
3. Lebovics E, Thung SN, Schaffner F, Radensky PW. The liver in the acquired immunodeficiency syndrome: a clinical and histologic study. Hepatology 1985;5:293-8.
4. Freiman JP, Helfert KE, Hamrell MR, Stein DS. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993;7:379-85.
5. Chattha G, Arieff AI, Cummings C, Tiemey LM Jr. Lactic acidosis complicating the acquired immunodeficiency syndrome. Annals Intern Med 1993;118:37-9.
6. Touchette N. HBV-drug deaths prompt restudy of similar antivirals. Journal of NIH Research 1993;5:33-5.
7. Parker WB, Cheng YC. Mitochondrial toxicity of antiviral nucleoside analogs. Journal of NIH Research 1994;6:57-61.
8. Kuller LH, Perper JA, Cooper M, Fisher R. An epidemic of deaths attributed to fatty liver in Baltimore. Prev Med 1974;3:61-79.
9. Macilwain C. NIH, FDA seek lessons from hepatitis B drug trial deaths. Nature 1993; 364:275.
10. Gradon JD, Sepkowitz DV. Massive hepatic enlargement with fatty change associated with ketoconazole. Drug Intell Clin Pharm 1990; 24:1175-6.
11. Wells C, Lever AML. Dose-dependent fluconazole hepatotoxicity proven on biopsy an rechallenge [letter], J Infect 1992;24:111-2.
12. Munoz P, Moreno S, Berenguer J, Bemaldo de Quiros JCL, Bouza E. Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome [letter]. Arch Intern Med 1991;151:1020-1.
13. Maddrey WC, Boitnott JK. Drug-induced chronic liver disease. Gastroenterology 1977;72:1348-53.
14. Lai KK, Gang DL, Zawacki JK, Cooley TP. Fulminant hepatic failure associated with 2’,3’-dideoxyinosine (ddl). Ann Intern Med 1991;115:283-4.
15. Jolliet P, Widmann J-J. Reye’s syndrome in adult with AIDS [letter]. Lancet 1990; 335:1457.
16. Modica-Napolitano JS. AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem Biophys Res Commun 1993;194:170-7.
17. Medina DJ, Tsai C-H, Hsiung GD, Cheng Y-C. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob Agents Chemother 1994;38:1824-8.
18. Chen C-H, Vazquez-Padua M, Cheng Y-C. Effect of anti-human immune deficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 1991;39:625-8.
19. Chen C-H, Cheng Y-C. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2’3’-dideoxycytidine. J Biol Chem 1989;264:11934-7.